MétaCan
Menu
Back to cohort
Record W4288843991 · doi:10.1001/jamaneurol.2022.2379

Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment

2022· article· en· W4288843991 on OpenAlexaff
Cherie Strikwerda‐Brown, Diana A. Hobbs, Julie Gonneaud, Frédéric St‐Onge, Alexa Pichet Binette, Hazal Ozlen, Karine Provost, Jean‐Paul Soucy, Rachel F. Buckley, Tammie L.S. Benzinger, John C. Morris, Victor L. Villemagne, Vincent Doré, Reisa A. Sperling, Keith A. Johnson, Christopher C. Rowe, Brian A. Gordon, Judes Poirier, John C.S. Breitner, Sylvia Villeneuve, Angela Tam, Anne Labonté, Anne‐Marie Faubert, Axel Mathieu, Cécile Madjar, Charles Edouard Carrier, Christian Dansereau, Christina Kazazian, Claude Lepage, Cynthia Picard, David Maillet, Diane Michaud, Doris Couture, Doris Dea, A. Claudio Cuello, Alan Barkun, Alan C. Evans, Blandine Courcot, Christine Tardif, Clément Debacker, Clifford R. Jack, David Fontaine, David S. Knopman, Gerhard Multhaup, Jamie Near, Jeannie‐Marie Leoutsakos, Jean‐Robert Maltais, Jason Brandt, Jens C. Pruessner, Laksanun Cheewakriengkrai, Lisa-Marie Mà ⁄ nter, D. Louis Collins, M. Mallar Chakravarty, Mark A. Sager, Marina Dauar‐Tedeschi, Mark J. Eisenberg, Natasha Rajah, Paul Aisen, Paule‐Joanne Toussaint, Pedro Rosa‐Neto, Pierre Bellec, Penelope Kostopoulos, Pierre Étienne, Pierre N. Tariot, Pierre Orban, Rick Hoge, Ronald G. Thomas, Serge Gauthier, Suzanne Craft, Thomas J. Montine, Vasavan Nair, Véronique D. Bohbot, Vinod Venugopalan, Vladimir Fonov, Yasser Ituria‐Medina, Zaven S. Khachaturian, Eduard Teigner, Elena Anthal, Elsa Yu, Fabiola Ferdinand, Galina Pogossova, Ginette Mayrand, Guerda Duclair, Guylaine Gagné, Holly Newbold‐Fox, Illana Leppert, Isabelle Vallée, Jacob W. Vogel, Jennifer Tremblay‐Mercier, Joanne Frenette, Josée Frappier, Justin Kat, Justin Miron, Karen Wan, Laura Mahar, Leopoldina Carmo, Louise Théroux, Mahsa Dadar, Marianne Dufour, Marie‐Élyse Lafaille‐Magnan, Melissa Appleby, Mélissa Savard, Miranda Tuwaig, Mirela Petkova, Pierre Rioux, P.T. Meyer, Rana El‐Khoury, Renee Gordon, Renuka Giles, Samir Das, Seqian Wang, Shirin Tabrizi, Sulantha Mathotaarachchi, Sylvie Dubuc, Tanya Lee, Thomas Beaudry, Valérie Gervais, Véronique Pagé, Gà ⁄ lebru Ayranci, Tharick A. Pascoal, René Desautels, Fatiha Benbouhoud, Eunice Farah Saint‐Fort, Sander C.J. Verfaillie, Sarah Farzin, Alyssa Salaciak, Stéphanie Tullo, Étienne Vachon‐Presseau, Leslie‐Ann Daoust, Theresa Köbe, Nathan Spreng, Melissa McSweeney, Nathalie Nilsson, Morteza Pishnamazi, Christophe Bedetti, Louise Hudon, Claudia Greco, Marianne Chapleau, Sophie Boutin, Maiya R. Geddes, Simon Ducharme, Gabriel Jean, Elisabeth Sylvain, Marie‐Josee Élie, Gloria Leblond‐Baccichet, Julie Bailly, Béry Mohammediyan, Yalin Chen, Jordana Remz, Dorene M. Rentz, Rebecca E. Amariglio, Deborah Blacker, Jasmeer P. Chhatwal, Brad C. Dickerson, Nancy J. Donovan, Michelle E. Farrell, Geoffroy Gagliardi, Jennifer R. Gatchel, Edmarie Guzmán‐Vélez, Heidi I.L. Jacobs, Roos J. Jutten, Cristina Lois Gómez, Gad A. Marshall, Kate Oaoo, Enmanuelle Pardilla‐Delgado, Julie C. Price, Prokopis C. Prokopiou, Yakeel T. Quiroz, Gretchen Reynolds, Aaron P. Schultz, Stephanie A. Schultz, Jorge Sepulcre, Irina Skylar-Scott, Patrizia Vannini, Clara Vila‐Castelar, Hyun‐Sik Yang, Colin L. Masters, Larry D. Ward, Paul Maruff, Christopher Fowler, Ralph N. Martins, Stephanie Rainy-Smith, Kevin Taddei, Belinda M. Brown, Simon M. Laws, Jürgen Fripp, Pierrick Bourgeat

Bibliographic record

VenueJAMA Neurology · 2022
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsMontreal Neurological Institute and HospitalCentre Hospitalier de l’Université de MontréalMcGill UniversityDouglas Mental Health University Institute
FundersNational Institute on Aging
KeywordsDementiaBiomarkerCognitive declineCohortPositron emission tomographyClinical Dementia RatingMedicinePopulationInternal medicineAlzheimer's diseaseDiseaseCohort studyPsychologyOncologyNuclear medicine

Abstract

fetched live from OpenAlex

Importance: National Institute on Aging-Alzheimer's Association (NIA-AA) workgroups have proposed biological research criteria intended to identify individuals with preclinical Alzheimer disease (AD). Objective: To assess the clinical value of these biological criteria to identify older individuals without cognitive impairment who are at near-term risk of developing symptomatic AD. Design, Setting, and Participants: This longitudinal cohort study used data from 4 independent population-based cohorts (PREVENT-AD, HABS, AIBL, and Knight ADRC) collected between 2003 and 2021. Participants were older adults without cognitive impairment with 1 year or more of clinical observation after amyloid β and tau positron emission tomography (PET). Median clinical follow-up after PET ranged from 1.94 to 3.66 years. Exposures: Based on binary assessment of global amyloid burden (A) and a composite temporal region of tau PET uptake (T), participants were stratified into 4 groups (A+T+, A+T-, A-T+, A-T-). Presence (+) or absence (-) of neurodegeneration (N) was assessed using temporal cortical thickness. Main Outcomes and Measures: Each cohort was analyzed separately. Primary outcome was clinical progression to mild cognitive impairment (MCI), identified by a Clinical Dementia Rating score of 0.5 or greater in Knight ADRC and by consensus committee review in the other cohorts. Clinical raters were blind to imaging, genetic, and fluid biomarker data. A secondary outcome was cognitive decline, based on a slope greater than 1.5 SD below the mean of an independent subsample of individuals without cognitive impairment. Outcomes were compared across the biomarker groups. Results: Among 580 participants (PREVENT-AD, 128; HABS, 153; AIBL, 48; Knight ADRC, 251), mean (SD) age ranged from 67 (5) to 76 (6) years across cohorts, with between 55% (137/251) and 74% (95/128) female participants. Across cohorts, 33% to 83% of A+T+ participants progressed to MCI during follow-up (mean progression time, 2-2.72 years), compared with less than 20% of participants in other biomarker groups. Progression further increased to 43% to 100% when restricted to A+T+(N+) individuals. Cox proportional hazard ratios for progression to MCI in the A+T+ group vs other biomarker groups were all 5 or greater. Many A+T+ nonprogressors also showed longitudinal cognitive decline, while cognitive trajectories in other groups remained predominantly stable. Conclusions and Relevance: The clinical prognostic value of NIA-AA research criteria was confirmed in 4 independent cohorts, with most A+T+(N+) older individuals without cognitive impairment developing AD symptoms within 2 to 3 years.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.254
Teacher spread0.248 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations133
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueJAMA NeurologySame topicDementia and Cognitive Impairment ResearchFrench-language works237,207